Jelly Roll is opening up about what it took to lose nearly 300 lbs. In an interview with Men’s Health published in January 2025, he explained, “I just remember everyone telling me GLP-1s, or taking ...

With buzzy medications like Ozempic and Mounjaro making headlines for blood sugar management, it’s easy to forget that some medications have been helping patients with type 2 diabetes for decades.

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged. Study: Effect of metformin on insulin ...

A Garvan Institute of Medical Research-led clinical trial has found that using the type 2 diabetes (T2D) drug metformin reduces insulin needs in type 1 diabetes (T1D), a finding that could potentially ...

Rutgers scientists found that metformin can blunt many of the metabolic and cardiovascular improvements normally produced by exercise. Participants who took the drug saw reduced gains in fitness, ...

NEW ORLEANS, LA—The diabetes drug metformin can reduce recurrence of atrial arrhythmia for patients with overweight and obesity undergoing catheter ablation even if they’re not diabetic, results from ...

A common diabetes drug could dampen some of the key benefits of exercise, a new study has found. Researchers from Rutgers University discovered that adults who took metformin, a widely used generic ...

Please provide your email address to receive an email when new articles are posted on . Metformin did not improve 6-minute walk distance in patients with peripheral artery disease but no diabetes.

A common diabetes drug could be sabotaging the health benefits that a patient might expect from a daily walk, a new study says. Metformin appears to blunt improvements in blood pressure, fitness and ...

“Metformin blunted that observation, suggesting one type of exercise intensity is not better either with the drug for blood vessel health.” Since 2006, medication and lifestyle changes have been ...

A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease: exercise. That is the conclusion of a Rutgers-led study published in The Journal of ...

Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma The Metformin Active Surveillance Trial (MAST) was a multicenter, randomized, double-blind, placebo-controlled phase III trial ...